+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Precision Medicine Market Size, Share & Trends Analysis Report by Application (Diagnostics, Therapeutics), End-use, Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 125 Pages
  • June 2024
  • Region: Global
  • Grand View Research
  • ID: 5899549
Description Jump to:
The global precision medicine market size is expected to reach USD 249.24 billion by 2030 growing at a CAGR of 16.3% from 2024 to 2030. Trends such as introduction of cost-effective genomic and molecular biology testing methods, increasing prevalence of cancer and rare diseases, and rising use of big data in precision medicine are some of the key factors boosting market growth.

The Human Genome Project introduced some marvelous cutting-edge techniques such as whole genome sequencing and targeted sequencing. These technologies are being used by researchers for the study of genomes and creation of personalized therapies for treatment of various illnesses. Today, the prevalence of diseases in areas such as oncology, immunology, and neurology has rapidly increased across the globe.

Researchers, healthcare professionals, and big pharma and biotech companies are working together to recognize new focused treatments options for the wellbeing of patients. Currently, there are many therapies and drugs under clinical trials for treatment of different types of cancers. Moreover, researchers have also shown an inclination toward development of precision medicines and diagnostics in non-oncologic disease areas.

Apart from therapeutics, the diagnostics field has also witnessed rapid growth in the past few years. The use of next generation sequencing (NGS), biomarkers, companion diagnostics, and esoteric tests can possibly change and affect prescription patterns of pharmaceutical medicines. Personalized medicines have very high chances of becoming a massive success in the next 20 years and have the capacity to treat and cure a few obstinate illnesses, which was not possible before.

Involvement of government and regulatory bodies has played a very important role in the growth of this field. In 2015, the then U.S. government announced the launch of the Precision Medicine Initiative. The following year, China launched the China Precision Medicine Initiative, which is a 15-year project that aims to build the country as a leader in development of precision therapies.

At present, more than 40% of the medications in biotech and pharmaceutical companies’ improvement pipeline incorporate biomarkers. The overview likewise recommended that some biopharmaceutical organizations have collaborated and joint their ventures in the past five years and are expected to continue doing so in the coming years. The diagnostic and therapeutic precision medicine market thus holds immense potential and is quickly turning into a fundamental segment of patient care.

Precision Medicine Market Report Highlights

  • The therapeutics segment led the market in 2023 and is expected to grow at a CAGR of 15.8% over the forecast period.
  • The hospitals segment led the market with a revenue share of 60.0% in 2023. Hospitals provide the ideal setting for personalized medicine due to their comprehensive infrastructure and access to diverse patient populations.
  • The North America precision medicine market accounted for 53.62% share in 2023. PMC report published in 2022 notes that personalized medicines now account for more than one in four drugs approved by the FDA since 2014.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Application
1.2.2. End-use
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Application and End-use outlook
2.2.2. Regional outlook
2.3. Competitive Insights
Chapter 3. Precision Medicine Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Technological advancements in next-generation sequencing
3.2.1.2. Expanding portfolio of companion/associated diagnostics
3.2.1.3. Increasing prevalence of cancer & usage of biomarkers for precision medicine cancer therapy
3.2.1.4. Growing healthcare expenditure triggering development of effective precision medicine
3.2.2. Market restraint analysis
3.2.2.1. Presence of nonvalue-based precision medicine diagnostics reimbursement policy
3.2.2.2. Lack of proper intellectual property regulations for precision medical technologies
3.2.2.3. Nonstructural development of biomarkers
3.3. Market opportunity analysis
3.3.1.1. Advancements in genomic technologies
3.4. Precision Medicine Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
3.4.3. Pricing Analysis
3.4.4. Volume Analysis (Instruments)
Chapter 4. Precision Medicine Market: Application Estimates & Trend Analysis
4.1. Global Precision Medicine Market: Application Dashboard
4.2. Global Precision Medicine Market: Application Movement Analysis
4.3. Global Precision Medicine Market by Application, Revenue
4.4. Diagnostics
4.4.1. Diagnostics market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Genetic Testing
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Direct to Consumer Tests
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Esoteric Tests
4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5. Others
4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Therapeutics
4.5.1. Therapeutics market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2. Pharmaceuticals
4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2.2. Oncology
4.5.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2.3. Respiratory Disease
4.5.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2.4. Skin Diseases
4.5.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2.5. CNS Disorders
4.5.2.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2.6. Immunology
4.5.2.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2.7. Genetic Diseases
4.5.2.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2.8. Others
4.5.2.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3. Medical Devices
4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.4. Others
4.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Precision Medicine Market: End-use Estimates & Trend Analysis
5.1. Global Precision Medicine Market: End-use Dashboard
5.2. Global Precision Medicine Market: End-use Movement Analysis
5.3. Global Precision Medicine Market by End-use, Revenue
5.4. Home care
5.4.1. Home care market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Hospitals
5.5.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Clinical Laboratories
5.6.1. Clinical Laboratories market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Others
5.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Precision Medicine Market: Regional Estimates & Trend Analysis by Category, Application, End-use and Methodology
6.1. Regional Dashboard
6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.3. North America
6.3.1. U.S.
6.3.1.1. Key country dynamics
6.3.1.2. Regulatory framework/ reimbursement structure
6.3.1.3. Competitive scenario
6.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
6.3.2. Canada
6.3.2.1. Key country dynamics
6.3.2.2. Regulatory framework/ reimbursement structure
6.3.2.3. Competitive scenario
6.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
6.3.3. Mexico
6.3.3.1. Key country dynamics
6.3.3.2. Regulatory framework/ reimbursement structure
6.3.3.3. Competitive scenario
6.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
6.4. Europe
6.4.1. UK
6.4.1.1. Key country dynamics
6.4.1.2. Regulatory framework/ reimbursement structure
6.4.1.3. Competitive scenario
6.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Germany
6.4.2.1. Key country dynamics
6.4.2.2. Regulatory framework/ reimbursement structure
6.4.2.3. Competitive scenario
6.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. France
6.4.3.1. Key country dynamics
6.4.3.2. Regulatory framework/ reimbursement structure
6.4.3.3. Competitive scenario
6.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
6.4.4. Italy
6.4.4.1. Key country dynamics
6.4.4.2. Regulatory framework/ reimbursement structure
6.4.4.3. Competitive scenario
6.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
6.4.5. Spain
6.4.5.1. Key country dynamics
6.4.5.2. Regulatory framework/ reimbursement structure
6.4.5.3. Competitive scenario
6.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
6.4.6. Norway
6.4.6.1. Key country dynamics
6.4.6.2. Regulatory framework/ reimbursement structure
6.4.6.3. Competitive scenario
6.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
6.4.7. Sweden
6.4.7.1. Key country dynamics
6.4.7.2. Regulatory framework/ reimbursement structure
6.4.7.3. Competitive scenario
6.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
6.4.8. Denmark
6.4.8.1. Key country dynamics
6.4.8.2. Regulatory framework/ reimbursement structure
6.4.8.3. Competitive scenario
6.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/ reimbursement structure
6.5.1.3. Competitive scenario
6.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
6.5.2. China
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
6.5.3. India
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
6.5.4. Australia
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework/ reimbursement structure
6.5.4.3. Competitive scenario
6.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
6.5.5. South Korea
6.5.5.1. Key country dynamics
6.5.5.2. Regulatory framework/ reimbursement structure
6.5.5.3. Competitive scenario
6.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
6.5.6. Thailand
6.5.6.1. Key country dynamics
6.5.6.2. Regulatory framework/ reimbursement structure
6.5.6.3. Competitive scenario
6.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/ reimbursement structure
6.6.1.3. Competitive scenario
6.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
6.6.2. Argentina
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
6.7. MEA
6.7.1. South Africa
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework/ reimbursement structure
6.7.1.3. Competitive scenario
6.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
6.7.2. Saudi Arabia
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
6.7.3. UAE
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/ reimbursement structure
6.7.3.3. Competitive scenario
6.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
6.7.4. Kuwait
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework/ reimbursement structure
6.7.4.3. Competitive scenario
6.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2023
7.3.4. F. Hoffmann-La Roche Ltd
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Siemens Healthineers AG
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Janssen Global Services, LLC
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Illumina, Inc.
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Quest Diagnostics Incorporated
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. 23andMe, Inc.
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. NeoDiagnostix
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Myriad Genetics
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives
7.3.12. Medtronic
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Product benchmarking
7.3.12.4. Strategic initiatives
7.3.13. GE Healthcare
7.3.13.1. Company overview
7.3.13.2. Financial performance
7.3.13.3. Product benchmarking
7.3.13.4. Strategic initiatives
7.3.14. Abbott
7.3.14.1. Company overview
7.3.14.2. Financial performance
7.3.14.3. Product benchmarking
7.3.14.4. Strategic initiatives
7.3.15. QIAGEN
7.3.15.1. Company overview
7.3.15.2. Financial performance
7.3.15.3. Product benchmarking
7.3.15.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 North America precision medicine market, by region, 2018-2030 (USD Million)
Table 3 North America precision medicine market, by application, 2018-2030 (USD Million)
Table 4 North America precision medicine market, by end-use, 2018-2030 (USD Million)
Table 5 U.S. precision medicine market, by application, 2018-2030 (USD Million)
Table 6 U.S. precision medicine market, by end-use, 2018-2030 (USD Million)
Table 7 Canada precision medicine market, by application, 2018-2030 (USD Million)
Table 8 Canada precision medicine market, by end-use, 2018-2030 (USD Million)
Table 9 Mexico precision medicine market, by application, 2018-2030 (USD Million)
Table 10 Mexico precision medicine market, by end-use, 2018-2030 (USD Million)
Table 11 Europe precision medicine market, by region, 2018-2030 (USD Million)
Table 12 Europe precision medicine market, by application, 2018-2030 (USD Million)
Table 13 Europe precision medicine market, by end-use, 2018-2030 (USD Million)
Table 14 Germany precision medicine market, by application, 2018-2030 (USD Million)
Table 15 Germany precision medicine market, by end-use, 2018-2030 (USD Million)
Table 16 UK precision medicine market, by application, 2018-2030 (USD Million)
Table 17 UK precision medicine market, by end-use, 2018-2030 (USD Million)
Table 18 France precision medicine market, by application, 2018-2030 (USD Million)
Table 19 France precision medicine market, by end-use, 2018-2030 (USD Million)
Table 20 Italy precision medicine market, by application, 2018-2030 (USD Million)
Table 21 Italy precision medicine market, by end-use, 2018-2030 (USD Million)
Table 22 Spain precision medicine market, by application, 2018-2030 (USD Million)
Table 23 Spain precision medicine market, by end-use, 2018-2030 (USD Million)
Table 24 Denmark precision medicine market, by application, 2018-2030 (USD Million)
Table 25 Denmark precision medicine market, by end-use, 2018-2030 (USD Million)
Table 26 Sweden precision medicine market, by application, 2018-2030 (USD Million)
Table 27 Sweden precision medicine market, by end-use, 2018-2030 (USD Million)
Table 28 Norway precision medicine market, by application, 2018-2030 (USD Million)
Table 29 Norway precision medicine market, by end-use, 2018-2030 (USD Million)
Table 30 Asia Pacific precision medicine market, by region, 2018-2030 (USD Million)
Table 31 Asia Pacific precision medicine market, by application, 2018-2030 (USD Million)
Table 32 Asia Pacific precision medicine market, by end-use, 2018-2030 (USD Million)
Table 33 China precision medicine market, by application, 2018-2030 (USD Million)
Table 34 China precision medicine market, by end-use, 2018-2030 (USD Million)
Table 35 Japan precision medicine market, by application, 2018-2030 (USD Million)
Table 36 Japan precision medicine market, by end-use, 2018-2030 (USD Million)
Table 37 India precision medicine market, by application, 2018-2030 (USD Million)
Table 38 India precision medicine market, by end-use, 2018-2030 (USD Million)
Table 39 South Korea precision medicine market, by application, 2018-2030 (USD Million)
Table 40 South Korea precision medicine market, by end-use, 2018-2030 (USD Million)
Table 41 Australia precision medicine market, by application, 2018-2030 (USD Million)
Table 42 Australia precision medicine market, by end-use, 2018-2030 (USD Million)
Table 43 Thailand precision medicine market, by application, 2018-2030 (USD Million)
Table 44 Thailand precision medicine market, by end-use, 2018-2030 (USD Million)
Table 45 Latin America precision medicine market, by region, 2018-2030 (USD Million)
Table 46 Latin America precision medicine market, by application, 2018-2030 (USD Million)
Table 47 Latin America precision medicine market, by end-use, 2018-2030 (USD Million)
Table 48 Brazil precision medicine market, by application, 2018-2030 (USD Million)
Table 49 Brazil precision medicine market, by end-use, 2018-2030 (USD Million)
Table 50 Argentina precision medicine market, by application, 2018-2030 (USD Million)
Table 51 Argentina precision medicine market, by end-use, 2018-2030 (USD Million)
Table 52 MEA precision medicine market, by region, 2018-2030 (USD Million)
Table 53 MEA precision medicine market, by application, 2018-2030 (USD Million)
Table 54 MEA precision medicine market, by end-use, 2018-2030 (USD Million)
Table 55 South Africa precision medicine market, by application, 2018-2030 (USD Million)
Table 56 South Africa precision medicine market, by end-use, 2018-2030 (USD Million)
Table 57 Saudi Arabia precision medicine market, by application, 2018-2030 (USD Million)
Table 58 Saudi Arabia precision medicine market, by end-use, 2018-2030 (USD Million)
Table 59 UAE precision medicine market, by application, 2018-2030 (USD Million)
Table 60 UAE precision medicine market, by end-use, 2018-2030 (USD Million)
Table 61 Kuwait precision medicine market, by application, 2018-2030 (USD Million)
Table 62 Kuwait precision medicine market, by end-use, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Primary interviews in North America
Figure 5 Primary interviews in Europe
Figure 6 Primary interviews in Asia Pacific
Figure 7 Primary interviews in Latin America
Figure 8 Primary interviews in MEA
Figure 9 Market research approaches
Figure 10 Value-chain-based sizing & forecasting
Figure 11 QFD modeling for market share assessment
Figure 12 Market formulation & validation
Figure 13 Precision medicine market: market outlook
Figure 14 Precision medicine competitive insights
Figure 15 Parent market outlook
Figure 16 Related/ancillary market outlook
Figure 17 Precision medicine market driver impact
Figure 18 Precision medicine market restraint impact
Figure 19 Precision medicine market: Application movement analysis
Figure 20 Precision medicine market: Application outlook and key takeaways
Figure 21 Diagnostics estimates and forecast, 2018-2030 (USD Million)
Figure 22 Genetic tests market estimates and forecast, 2018-2030 (USD Million)
Figure 23 Direct to Consumer Tests estimates and forecast, 2018-2030 (USD Million)
Figure 24 Esoteric Tests market estimates and forecast, 2018-2030 (USD Million)
Figure 25 Others market estimates and forecast, 2018-2030 (USD Million)
Figure 26 Therapeutics market estimates and forecast, 2018-2030 (USD Million)
Figure 27 Pharmaceuticals market estimates and forecast, 2018-2030 (USD Million)
Figure 28 Oncology estimates and forecast, 2018-2030 (USD Million)
Figure 29 Respiratory Diseases market estimates and forecast, 2018-2030 (USD Million)
Figure 30 Skin Diseases market estimates and forecast, 2018-2030 (USD Million)
Figure 31 CNS Disorders market estimates and forecast, 2018-2030 (USD Million)
Figure 32 Immunology estimates and forecast, 2018-2030 (USD Million)
Figure 33 Genetic Diseases market estimates and forecast, 2018-2030 (USD Million)
Figure 34 Others market estimates and forecast, 2018-2030 (USD Million)
Figure 35 Medical Devices market estimates and forecast, 2018-2030 (USD Million)
Figure 36 Others market estimates and forecast, 2018-2030 (USD Million)
Figure 37 Precision medicine market: End-use movement analysis
Figure 38 Precision medicine market: End-use outlook and key takeaways
Figure 39 Home care market estimates and forecast, 2018-2030 (USD Million)
Figure 40 Hospitals estimates and forecast, 2018-2030 (USD Million)
Figure 41 Clinical laboratories market estimates and forecast, 2018-2030 (USD Million)
Figure 42 Others market estimates and forecast, 2018-2030 (USD Million)
Figure 43 Global precision medicine market: Regional movement analysis
Figure 44 Global precision medicine market: Regional outlook and key takeaways
Figure 45 Global precision medicine market share and leading players
Figure 46 North America, by country
Figure 47 North America market estimates and forecasts, 2018-2030 (USD Million)
Figure 48 U.S. key country dynamics
Figure 49 U.S. market estimates and forecasts, 2018-2030 (USD Million)
Figure 50 Canada key country dynamics
Figure 51 Canada market estimates and forecasts, 2018-2030 (USD Million)
Figure 52 Mexico key country dynamics
Figure 53 Mexico market estimates and forecasts, 2018-2030 (USD Million)
Figure 54 Europe market estimates and forecasts, 2018-2030 (USD Million)
Figure 55 UK key country dynamics
Figure 56 UK market estimates and forecasts, 2018-2030 (USD Million)
Figure 57 Germany key country dynamics
Figure 58 Germany market estimates and forecasts, 2018-2030 (USD Million)
Figure 59 France key country dynamics
Figure 60 France market estimates and forecasts, 2018-2030 (USD Million)
Figure 61 Italy key country dynamics
Figure 62 Italy market estimates and forecasts, 2018-2030 (USD Million)
Figure 63 Spain key country dynamics
Figure 64 Spain market estimates and forecasts, 2018-2030 (USD Million)
Figure 65 Denmark key country dynamics
Figure 66 Denmark market estimates and forecasts, 2018-2030 (USD Million)
Figure 67 Sweden key country dynamics
Figure 68 Sweden market estimates and forecasts, 2018-2030 (USD Million)
Figure 69 Norway key country dynamics
Figure 70 Norway market estimates and forecasts, 2018-2030 (USD Million)
Figure 71 Asia Pacific market estimates and forecasts, 2018-2030 (USD Million)
Figure 72 China key country dynamics
Figure 73 China market estimates and forecasts, 2018-2030 (USD Million)
Figure 74 Japan key country dynamics
Figure 75 Japan market estimates and forecasts, 2018-2030 (USD Million)
Figure 76 India key country dynamics
Figure 77 India market estimates and forecasts, 2018-2030 (USD Million)
Figure 78 Thailand key country dynamics
Figure 79 Thailand market estimates and forecasts, 2018-2030 (USD Million)
Figure 80 South Korea key country dynamics
Figure 81 South Korea market estimates and forecasts, 2018-2030 (USD Million)
Figure 82 Australia key country dynamics
Figure 83 Australia market estimates and forecasts, 2018-2030 (USD Million)
Figure 84 Latin America market estimates and forecasts, 2018-2030 (USD Million)
Figure 85 Brazil key country dynamics
Figure 86 Brazil market estimates and forecasts, 2018-2030 (USD Million)
Figure 87 Argentina key country dynamics
Figure 88 Argentina market estimates and forecasts, 2018-2030 (USD Million)
Figure 89 Middle East and Africa market estimates and forecasts, 2018-2030 (USD Million)
Figure 90 South Africa key country dynamics
Figure 91 South Africa market estimates and forecasts, 2018-2030 (USD Million)
Figure 92 Saudi Arabia key country dynamics
Figure 93 Saudi Arabia market estimates and forecasts, 2018-2030 (USD Million)
Figure 94 UAE key country dynamics
Figure 95 UAE market estimates and forecasts, 2018-2030 (USD Million)
Figure 96 Kuwait key country dynamics
Figure 97 Kuwait market estimates and forecasts, 2018-2030 (USD Million)
Figure 98 Market share of key market players- Precision medicine market

Companies Mentioned

  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers AG
  • Janssen Global Services, LLC
  • Illumina, Inc.
  • Quest Diagnostics Incorporated
  • 23andMe, Inc.
  • NeoDiagnostix
  • Myriad Genetics
  • Medtronic
  • GE Healthcare
  • Abbott
  • QIAGEN

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages125
PublishedJune 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 87.5 Billion
Forecasted Market Value ( USD ) by 2030 $ 249.24 Billion
Compound Annual Growth Rate16.3%
Regions CoveredGlobal
No. of Companies Mentioned12

Related Topics

Related Reports

Global Precision Medicine Market by Technology (Big Data Analytics, Bioinformatics, Companion Diagnostics), Application (CNS, Immunology, Oncology), End-User, Deployment - Forecast 2024-2030 - Product Image

Global Precision Medicine Market by Technology (Big Data Analytics, Bioinformatics, Companion Diagnostics), Application (CNS, Immunology, Oncology), End-User, Deployment - Forecast 2024-2030

  • Report
  • 180 Pages
  • Global
From
Global Oncology Precision Medicine Market by Type (Cell & Gene Therapy, Inhibitor drugs, Monoclonal Antibodies), Cancer Type (Breast Cancer, Cervical Cancer, Colorectal Cancer), End-use - Forecast 2024-2030 - Product Image

Global Oncology Precision Medicine Market by Type (Cell & Gene Therapy, Inhibitor drugs, Monoclonal Antibodies), Cancer Type (Breast Cancer, Cervical Cancer, Colorectal Cancer), End-use - Forecast 2024-2030

  • Report
  • 186 Pages
  • Global
From
Oncology Precision Medicine Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Type of Cancer Targeted, Route of Administration, Type of Molecule, Drug Class, Key Geographical Regions, Leading Drug Developers and Sales Forecast - Product Image

Oncology Precision Medicine Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Type of Cancer Targeted, Route of Administration, Type of Molecule, Drug Class, Key Geographical Regions, Leading Drug Developers and Sales Forecast

  • Report
  • 468 Pages
  • Global
From
Precision Medicine Market by Type (Inhibitors, Monoclonal Antibodies, Cell & Gene Therapy, Antivirals, Antiretroviral), Indication (Oncology, Rare diseases, Hematology, Infectious), End user (Hospitals & Clinics, Home care) & Region - Global Forecast to 2028 - Product Image

Precision Medicine Market by Type (Inhibitors, Monoclonal Antibodies, Cell & Gene Therapy, Antivirals, Antiretroviral), Indication (Oncology, Rare diseases, Hematology, Infectious), End user (Hospitals & Clinics, Home care) & Region - Global Forecast to 2028

  • Report
  • 234 Pages
  • Global
From
Precision Medicine Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Precision Medicine Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.